Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, ...
Leesburg, VA, May 25, 2022—According to ARRS’ American Journal of Roentgenology (AJR), adding diffusion-weighted MRI (DWI) to conventional MRI improves ...
The Society for Academic Emergency Medicine (SAEM) is pleased to announce the release of its second publication in a series ...
One of the greatest frustrations regarding urinary tract infections (UTIs) is that they so often recur. UTIs are caused by ...
NEW ORLEANS – More than 10 percent of cases of recurrent ductal carcinoma in situ (DCIS) of the breast were ...
Sophia Antipolis – 7 April 2022: Nearly half of heart disease patients have insomnia, according to research presented at ESC ...
PHOENIX – A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...
Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a Seminal Session during the Society ...
The repeated explosions from the recurrent nova RS Ophiuchi (RS Oph) provide favorable environments for accelerating protons to very high ...
Its use as an alternative to antibiotics may also help tackle the global burden of antibiotic resistance, say the researchers. ...
Findings from a recent study evaluating the impact of the antibiotic azithromycin during severe respiratory syncytial virus (RSV) bronchiolitis overwhelmingly ...
HOUSTON ― A study led by researchers at The University of Texas MD Anderson Cancer Center reported that the MEK ...
Embargoed until 4 a.m. CT/5 a.m. ET Thursday, Feb. 3, 2022 NEW ORLEANS, Feb. 3, 2022 — Among younger adults ...
DETROIT (Dec. 20, 2021) – Surgeons at Henry Ford Health System have treated a patient with a recurrent brain tumor ...
Two University of Wyoming researchers decided to pick each other’s brain, so to speak. Specifically, they examined the importance of ...
Lugano, Switzerland, 18 September 2021 – The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients with recurrent, persistent or metastatic cervical cancer, according to late breaking results from the KEYNOTE-826 ...
PHOENIX, Ariz., Sept. 9, 2021 - The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development ...
